Levomilnacipran
| CAS No. | 96847-55-1 | Cat. No. | BCP28780 |
| Name | Levomilnacipran | ||
| Synonyms | F2695; F 2695; F-2695; | ||
| Formula | C15H22N2O | M. Wt | 246.35 |
| Description | Levomilnacipran is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Forest Laboratories and Pierre Fabre Group, and was approved by the Food and Drug Administration in July 2013. Levomilnacipran is the levo- enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor (SNRI). | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | SSRI | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.